StonvexLoading…
StonvexStonvexStonvexCore line items from GDRX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $796.85M | $792.32M | $750.26M | $766.55M |
Operating Income | $87.49M | $65.85M | $-27.01M | $1.74M |
Net Income | $30.44M | $16.39M | $-8.87M | $-32.83M |
EPS (Diluted) | $0.09 | $0.04 | $-0.02 | $-0.08 |
Total Assets | $1.40B | $1.39B | $1.59B | $1.60B |
Total Liabilities | $787.80M | $663.41M | $826.84M | $789.80M |
Cash & Equivalents | $261.82M | $448.35M | $672.30M | $757.16M |
Free Cash Flow OCF − CapEx | $164.38M | $182.65M | $137.25M | $142.81M |
Shares Outstanding | 356.97M | 392.17M | 410.31M | 412.86M |